Bruce Dezube
Directeur Technique/Scientifique/R&D chez MUSTANG BIO, INC.
Provenance du réseau au premier degré de Bruce Dezube
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 20 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Bruce Dezube via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| ORIGO ACQUISITION CORP | Financial Conglomerates | Chief Executive Officer Chairman Director/Board Member Director/Board Member | |
| AVENUE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Investor Relations Contact | |
| CHECKPOINT THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member Investor Relations Contact | |
| FORTRESS BIOTECH, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Comptroller/Controller/Auditor | |
| TG THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Chief Executive Officer Director/Board Member | |
| JOURNEY MEDICAL CORPORATION | Pharmaceuticals: Major | Chairman Director/Board Member Investor Relations Contact | |
| Yeshiva University | College/University | Undergraduate Degree Undergraduate Degree | |
Opus Point Partners Management LLC
 Opus Point Partners Management LLC Investment ManagersFinance Opus Point Partners Management LLC (OPPM) is a hedge fund manager headquartered in New York City. The firm was founded by Lindsay Rosenwald and Michael Weiss in 2009. They are owned by Opus Point Partners LLC, which is a subsidiary of Weiss & Co. LLC. OPPM manages investments that are dedicated to healthcare and life science. | Investment Managers | Chief Executive Officer Founder | |
| NATIONAL HOLDINGS CORPORATION | Investment Banks/Brokers | Chairman Director/Board Member | |
| Columbia Law School | College/University | Graduate Degree Graduate Degree | |
Baergic Bio, Inc.
 Baergic Bio, Inc. Pharmaceuticals: MajorHealth Technology Baergic Bio, Inc. develops therapeutic drugs for the treatment of central nervous system disorders. It offers oncology, rare diseases, and gene therapy. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Cyprium Therapeutics, Inc.
 Cyprium Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Fortress Biotech, Inc., Cyprium Therapeutics, Inc. is an American New York-based company focused on developing novel therapies for the treatment of Menkes disease and related copper metabolism disorders. The company was granted FDA breakthrough therapy, fast track, and rare pediatric disease designations, as well as FDA orphan drug designation for both Cutx-101 and AAV-ATP7A. The European Medicines Agency also granted orphan drug designation to Cyprium. In March 2017, Cyprium entered into a cooperative research and development agreement with the Eunice Kennedy Shriver National Institute of Child Health and Human Development to advance the clinical development of Cutx-101 for the treatment of Menkes disease. In 2023, Cyprium completed the transfer of its proprietary rights and assigned its FDA documents pertaining to Cutx-101 to Sentynl Therapeutics, Inc. Cyprium and NICHD also previously entered into a worldwide, exclusive license agreement to develop and commercialize AAV-ATP7A gene therapy, which is currently in pre-clinical development. The company was founded in 2017 by Michael Sean Weiss, Lindsay Allan Rosenwald, and Lung S. Yam, who has been the CEO since then. | Miscellaneous Commercial Services | Founder Founder | |
Caelum Biosciences, Inc.
 Caelum Biosciences, Inc. BiotechnologyHealth Technology Caelum Biosciences, Inc. operates as a clinical-stage biotechnology company developing treatments for rare and life-threatening diseases. The company was founded in January 2017 and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member | |
Helocyte, Inc.
 Helocyte, Inc. Miscellaneous Commercial ServicesCommercial Services Helocyte, Inc. engages in the development and commercialization of immunotherapies for the prevention and treatment of cytomegalovirus or CMV (cancer and infectious disease). It focuses on developing PepVax, a HLA-restricted single antigen peptide vaccine for controlling CMV in allogeneic hematopoietic stem cell transplant recipients and Triplex. The company was founded by Donald J. Diamond in 2015 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Founder Director/Board Member | |
| Cellvation, Inc. | Chairman Director/Board Member | ||
| KERYX BIOPHARMACEUTICALS | Pharmaceuticals: Major | Founder Chief Executive Officer | |
Amerigen Pharmaceuticals Ltd.
 Amerigen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Amerigen Pharmaceuticals Ltd. engages in the development, manufacturing, and sale of generic pharmaceutical products. The company was founded in 2007 and is headquartered in Lyndhurst, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Albert Einstein College of Medicine, Inc. | College/University | Doctorate Degree | |
Memorial Sloan Kettering Cancer Center
 Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Memorial Sloan-Kettering Cancer Center operates as a private cancer center. It offers cancer care services to adult; and child and teen patients. Its services include risk assessment and screening; diagnosis and treatment; clinical trials; patient and caregiver education; and pediatric clinical trials. The company was founded by John J. Astor and Charlotte Astor in 1884 and is headquartered in New York, NY. | Hospital/Nursing Management | Corporate Officer/Principal | |
| Weill Cornell Medical College | College/University | Corporate Officer/Principal | |
| CONVATEC GROUP PLC | Medical Specialties | Corporate Officer/Principal | |
NYU Langone Hospitals
 NYU Langone Hospitals Hospital/Nursing ManagementHealth Services NYU Langone Hospitals provides health care services. It offers wide array of specialties, including cardiac and vascular care, cancer, inpatient and outpatient musculoskeletal care—including orthopedics, rheumatology, and rehabilitation—and a host of specialty children’s services. The company is headquartered in New York, NY. | Hospital/Nursing Management | Corporate Officer/Principal | |
| Roosevelt University | College/University | Masters Business Admin | |
| University of Florida | College/University | Undergraduate Degree | |
| American Brachytherapy Society | President | ||
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Yale School of Medicine | College/University | Doctorate Degree | |
| Princeton University | College/University | Undergraduate Degree | |
Arvinas Operations, Inc.
 Arvinas Operations, Inc. BiotechnologyHealth Technology Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT. | Biotechnology | Chief Executive Officer | |
On Demand Pharmaceuticals, Inc.
 On Demand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology On Demand Pharmaceuticals, Inc. is an innovative technology company that is transforming the way medicines are made. On Demand Pharmaceuticals is based in Richmond, VA and was founded by Shiu Fei Ling. The private company's breakthrough manufacturing technology platform, the Pharmacy on Demand (POD), allows for the production of medicines on demand, wherever and whenever they are needed. The company's mission is to provide an adequate, safe, and reliable supply of medicines to every community worldwide. | Pharmaceuticals: Major | Director of Finance/CFO | |
| The Bayit Association | Founder | ||
| American Friends of Shalva, Inc. | Corporate Officer/Principal | ||
| Carmel Academy, Inc. | College/University | Director/Board Member | |
Kingsbrook Partners LP
 Kingsbrook Partners LP Investment ManagersFinance Kingsbrook Partners LP is an independent hedge fund management firm headquartered in New York City. It was founded by Adam J. Chill, Scott M. Wallace and Ari J. Storch in 2009. The firm provides investment advice to high net worth clients. | Investment Managers | Founder | |
Stroock & Stroock & Lavan LLP
 Stroock & Stroock & Lavan LLP Miscellaneous Commercial ServicesCommercial Services Stroock & Stroock & Lavan LLP provides legal services. It is a law firm, which provides transactional and litigation guidance to multinational corporations, investment banks & venture capital firms in the U.S. and abroad. Its practice areas include corporate finance and legal services to financial institutions, energy, financial restructuring, insurance, intellectual property, litigation, and real estate. The company was founded in 1876 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Angelo, Gordon & Co. LP
 Angelo, Gordon & Co. LP Investment ManagersFinance Angelo, Gordon & Co. LP (Angelo Gordon) is a SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Michael L. Gordon in 1988. They were acquired by TPG, Inc. (NASDAQ: TPG) in 2023. Angelo Gordon invests on behalf of pension funds, corporations, endowments, foundations, sovereign wealth funds and individuals. | Investment Managers | Portfolio Manager-Equities | |
Aprinoia Therapeutics, Inc. /US/
 Aprinoia Therapeutics, Inc. /US/ BiotechnologyHealth Technology Aprinoia Therapeutics, Inc. operates as a global clinical-stage biopharmaceutical company. It develops imaging diagnostic tools, targeted therapy drugs, and other products. The company was founded in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Director of Finance/CFO | |
| Massachusetts College of Pharmacy & Health Science | College/University | Graduate Degree | |
| BRAINSTORM CELL THERAPEUTICS INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| The Society of Quality Assurance | President | ||
| LEGEND BIOTECH CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal | |
| The Johns Hopkins University | College/University | Undergraduate Degree | |
| Monmouth University | College/University | Graduate Degree | |
Carnegie Mellon University
 Carnegie Mellon University Other Consumer ServicesConsumer Services Carnegie Mellon University is an American school that operates as a college or university. It is located in Pittsburgh, Pennsylvania. | College/University | Undergraduate Degree | |
| University of Virginia | College/University | Graduate Degree | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer |
Statistiques
Internationale
| Etats-Unis | 47 |
| Îles Cayman | 3 |
| Royaume-Uni | 2 |
| Suisse | 2 |
Sectorielle
| Health Technology | 21 |
| Consumer Services | 15 |
| Finance | 7 |
| Commercial Services | 4 |
| Health Services | 3 |
Opérationnelle
| Director/Board Member | 41 |
| Corporate Officer/Principal | 28 |
| Chairman | 23 |
| Director of Finance/CFO | 22 |
| Chief Executive Officer | 15 |
Relations les plus connectées
| Insiders | |
|---|---|
| Michael Weiss | 25 |
| Lindsay Rosenwald | 23 |
| Neil Herskowitz | 22 |
| Eliot Lurier | 13 |
| Adam Chill | 11 |
| Brian Achenbach | 8 |
| James Murphy | 8 |
| Michael Zelefsky | 7 |
| Susan E. Ward | 7 |
| Manuel Litchman | 6 |
| Lynn E. Bayless | 5 |
| Greg Furrow | 5 |
| Albert Paszek | 5 |
| Jaclyn Jaffe | 4 |
| Rick Bodmer | 4 |
- Bourse
- Insiders
- Bruce Dezube
- Connexions Sociétés
